SBI Securities’s Cardio Diagnostics CDIO Stock Holding History

SBI Securities’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22	Hold	10	–	–	﹤0.01%	3825
2026 Q1	$20	Sell	10 -16	-62%	-$42	﹤0.01%	3764
2025 Q4	$70	Sell	26 -1	-4%	-$4	﹤0.01%	3516
2025 Q3	$108	Sell	27 -43	-61%	-$170	﹤0.01%	3491
2025 Q2	$252	Buy	70 +9	+15%	+$67	﹤0.01%	3238
2025 Q1	$601	Buy	61 +22	+56%	+$343	﹤0.01%	2792
2024 Q4	$1.06K	Buy	+39	New	+$541	﹤0.01%	2577

Other funds holding CDIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's CDIO Position: Q2 2026 in Review

SBI Securities held its Cardio Diagnostics (CDIO) position steady in Q2 2026 at 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3825.

SBI Securities first reported a position in CDIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.06K in Q4 2024. 3 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.

SBI Securities held 10 shares of Cardio Diagnostics worth $22 as of Q2 2026.
SBI Securities left its Cardio Diagnostics share count unchanged in Q2 2026.
Cardio Diagnostics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3825 holding.
SBI Securities first reported a position in Cardio Diagnostics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Cardio Diagnostics position peaked at $1.06K in Q4 2024.
3 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.